XPH holdings — State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF (XPH) held 67 positions with net assets of $428M as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 28.9% of the fund, led by State Street Global Advisors, DFTX, MBX.
XPH top holdings
- State Street Global Advisors — 8.58% ($36.8M)
- DFTX Definium Therapeutics Inc — 3.09% ($13.2M)
- MBX MBX Biosciences Inc — 2.72% ($11.6M)
- ALMS Alumis Inc — 2.14% ($9.17M)
- ATAI AtaiBeckley Inc — 2.13% ($9.11M)
- TRVI Trevi Therapeutics Inc — 2.12% ($9.10M)
- ELVN Enliven Therapeutics Inc — 2.09% ($8.97M)
- AMLX Amylyx Pharmaceuticals Inc — 2.04% ($8.72M)
- MANE VeraDermics Inc — 2.02% ($8.64M)
- LGND Ligand Pharmaceuticals Inc — 1.94% ($8.32M)
- NUVB Nuvation Bio Inc — 1.89% ($8.11M)
- EWTX Edgewise Therapeutics Inc — 1.88% ($8.07M)
- NKTR Nektar Therapeutics — 1.88% ($8.04M)
- LQDA Liquidia Corp — 1.86% ($7.99M)
- MAZE Maze Therapeutics Inc — 1.85% ($7.93M)
- HROW Harrow Inc — 1.81% ($7.73M)
- EYPT EyePoint Inc — 1.77% ($7.58M)
- AMRX Amneal Pharmaceuticals Inc — 1.72% ($7.39M)
- OCUL Ocular Therapeutix Inc — 1.71% ($7.35M)
- CORT Corcept Therapeutics Inc — 1.70% ($7.28M)
- Crinetics Pharmaceuticals Inc — 1.66% ($7.13M)
- PCRX Pacira BioSciences Inc — 1.65% ($7.08M)
- MRK Merck & Co Inc — 1.65% ($7.05M)
- INDV Indivior Pharmaceuticals Inc — 1.64% ($7.04M)
- ELAN Elanco Animal Health Inc — 1.64% ($7.04M)
What are XPH's top 10 holdings?
State Street Global Advisors (8.6%), DFTX (3.1%), MBX (2.7%), ALMS (2.1%), ATAI (2.1%), TRVI (2.1%), ELVN (2.1%), AMLX (2.0%), MANE (2.0%), LGND (1.9%).
How many stocks are in XPH?
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF reported 67 holdings as of June 30, 2026.